Literature DB >> 28540416

Breastfeeding initiation, duration, and reasons for weaning in patients with systemic lupus erythematosus.

Magdalena Acevedo1, Julia Pretini1, Marina Micelli1, Gabriel Sequeira2, Eduardo Kerzberg1.   

Abstract

To assess breastfeeding in patients with systemic lupus erythematosus (SLE), a cross-sectional study of patients with SLE compared to a non-SLE sample was performed. Patients who had pregnancies subsequent to their diagnosis of SLE and who were followed up in the hospital were interviewed. The group of non-SLE mothers consisted of patients who had no known rheumatic disease at the time of their pregnancy, and who were approached at the hospital paediatrics service waiting room. Thirty-six pregnancies in 31 patients with SLE and the same number of non-SLE mothers were studied. The number of SLE patients who did not initiate breastfeeding was higher than that of non-SLE mothers (19.4 vs 5.6%, respectively; p 0.07). The average duration of breastfeeding in SLE patients was 6 months (SD 6 months) versus 12 months (SD 8 months) in non-SLE mothers (log rank p: 0.003). Fifty-three percent of the non-SLE mothers indicated no particular reason for weaning, and considered that they had nursed their children a suitable amount of time. Conversely, SLE patients often set weaning in motion on the grounds that they had been placed on medication (41%). However, when the treatment was analysed, in 6 out of 12 cases, it consisted of low doses of either corticosteroids or hydroxychloroquine. Patients with SLE showed reduced rates of initiating breastfeeding. They also showed reduced duration of breastfeeding, and the reason for cessation was frequently cited to be therapies which were actually of low risk. Breastfeeding duration could be optimised by improving the level of information provided to patients.

Entities:  

Keywords:  Breastfeeding; Hydroxychloroquine; Systemic lupus erythematosus; Weaning

Mesh:

Substances:

Year:  2017        PMID: 28540416     DOI: 10.1007/s00296-017-3750-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.

Authors:  Arthur Kavanaugh; John J Cush; Mahmoud S Ahmed; Bonnie L Bermas; Eliza Chakravarty; Christina Chambers; Megan Clowse; Jeffrey R Curtis; Kathryn Dao; Gary D V Hankins; Gideon Koren; Seoyoung C Kim; Larissa Lapteva; Uma Mahadevan; Thomas Moore; Martha Nolan; Zhaoxia Ren; Lisa R Sammaritano; Sally Seymour; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-03       Impact factor: 4.794

Review 2.  Breastfeeding and the use of human milk.

Authors: 
Journal:  Pediatrics       Date:  2012-02-27       Impact factor: 7.124

Review 3.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis.

Authors:  Andrew Smyth; Guilherme H M Oliveira; Brian D Lahr; Kent R Bailey; Suzanne M Norby; Vesna D Garovic
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

4.  Breast-feeding in Athens, Greece: factors associated with its initiation and duration.

Authors:  Melina Theofilogiannakou; Maria Skouroliakou; Antonis Gounaris; Demosthenis Panagiotakos; Sophia L Markantonis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-09       Impact factor: 2.839

5.  Survey of antimalarial use in lupus pregnancy and lactation.

Authors:  Adeeba Al-Herz; Michael Schulzer; John M Esdaile
Journal:  J Rheumatol       Date:  2002-04       Impact factor: 4.666

6.  Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients.

Authors:  Yasumori Izumi; Taiichiro Miyashita; Kiyoshi Migita
Journal:  Tohoku J Exp Med       Date:  2014-09       Impact factor: 1.848

7.  Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss.

Authors:  Kathryn G Dewey; Laurie A Nommsen-Rivers; M Jane Heinig; Roberta J Cohen
Journal:  Pediatrics       Date:  2003-09       Impact factor: 7.124

8.  The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

Authors:  Carina Götestam Skorpen; Maria Hoeltzenbein; Angela Tincani; Rebecca Fischer-Betz; Elisabeth Elefant; Christina Chambers; Josè da Silva; Catherine Nelson-Piercy; Irene Cetin; Nathalie Costedoat-Chalumeau; Radboud Dolhain; Frauke Förger; Munther Khamashta; Guillermo Ruiz-Irastorza; Angela Zink; Jiri Vencovsky; Maurizio Cutolo; Nele Caeyers; Claudia Zumbühl; Monika Østensen
Journal:  Ann Rheum Dis       Date:  2016-02-17       Impact factor: 19.103

9.  Breastfeeding in mothers with systemic lupus erythematosus.

Authors:  M Noviani; S Wasserman; M E B Clowse
Journal:  Lupus       Date:  2016-02-16       Impact factor: 2.911

10.  EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Authors:  L Andreoli; G K Bertsias; N Agmon-Levin; S Brown; R Cervera; N Costedoat-Chalumeau; A Doria; R Fischer-Betz; F Forger; M F Moraes-Fontes; M Khamashta; J King; A Lojacono; F Marchiori; P L Meroni; M Mosca; M Motta; M Ostensen; C Pamfil; L Raio; M Schneider; E Svenungsson; M Tektonidou; S Yavuz; D Boumpas; A Tincani
Journal:  Ann Rheum Dis       Date:  2016-07-25       Impact factor: 19.103

View more
  2 in total

Review 1.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

2.  Analysis of the data on pregnancy and lactation provided by patient information leaflets of anti-rheumatic drugs in Argentina.

Authors:  Miguel Ormaza Sabando; Maira Arias Saavedra; Gabriel Sequeira; Eduardo Kerzberg
Journal:  Rheumatol Int       Date:  2018-01-13       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.